## IVZ: Invesco Ltd - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.3% in mid entry zone (3.0-6.0%), top quartile (89th pct) cross-sectional ranking. Short-term MRS_5 (1.9%) confirms momentum alignment. Outperforming sector by 3.5%. Caution: overbought RSI (72).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($25.38)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Invesco stock hits 52-week high at 27.3 USD**
- Source: Investing.com | 20251211T200613 | Bullish | Relevance: 99%
-  Invesco (IVZ) has reached a new 52-week high at $27.3 USD, reflecting robust investor confidence and a significant 52.75% increase over the past year. The asset management firm, with a market capitalization of $12.12 billion, also maintains a 3.12% dividend yield, though InvestingPro suggests it might be slightly overvalued. Recent activities include a slight decrease in AUM, a strategic partnership with LGT Capital Partners, and analyst target increases from BMO Capital and TD Cowen.

**2. A new partnership to help advisers rethink the possibilities of private markets**
- Source: Invesco | 20251209T050822 | Bullish | Relevance: 99%
-  Invesco has announced a new strategic partnership with LGT Capital Partners, a global specialist in alternative investing, to unlock new opportunities in private markets. This collaboration aims to provide financial advisers with multi-alternative private market solutions, initially focusing on the U.S. wealth and retirement channels. The partnership leverages the expertise and networks of both firms to offer enhanced growth, diversification, and innovation for investors.

**3. A new partnership to help advisers rethink the possibilities of private markets**
- Source: Invesco | 20251209T020859 | Bullish | Relevance: 98%
-  Invesco has announced a new strategic partnership with LGT Capital Partners, a leading global specialist in alternative investing. This collaboration aims to unlock new opportunities in private markets for investors by providing access to hard-to-reach segments like private equity, secondaries, private credit, and infrastructure. The partnership will focus on developing multi-alternative private markets solutions for the U.S. wealth and retirement channels, building on Invesco's existing success in the private markets space.

**4. Eagle Materials Inc $EXP Shares Sold by Invesco Ltd.**
- Source: MarketBeat | 20251211T112500 | Neutral | Relevance: 98%
-  Invesco Ltd. reduced its stake in Eagle Materials Inc. (NYSE:EXP) by 47.3% in Q2, selling 311,780 shares, but still holds 1.07% of the companyâ€™s stock valued at $70.3 million. Despite missing EPS estimates, Eagle Materials reported revenue that slightly exceeded expectations and maintains strong profitability. The company's stock is currently rated as a "Hold" by analysts with an average target price of $243.30, and a director recently purchased 1,000 shares.

**5. Key facts: Invesco repurchases $500M shares; BMO raises price target to $30**
- Source: TradingView | 20251210T200832 | Bullish | Relevance: 98%
- Invesco Ltd. repurchased $500 million of its preference shares from Massachusetts Mutual Life Insurance Company, leading to a 2.9% stock price increase. BMO Capital also raised its price target for Invesco (IVZ) to $30.00 from $28.00 per share. Additionally, Invesco announced the net asset value for its IVZ II Bulletshares 2029 USD Corp fund

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | BMO Capital | $30 | $28 | +7% |
| 2025-11-25 | Goldman Sachs | $26 | $26 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | BMO Capital | main | Outperform |
| 2025-11-25 | Goldman Sachs | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($2.51M) |
| Sells | 5 ($4.56M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Massachusetts Mutual: 18.3% (0.0%)
- Vanguard Group Inc: 11.7% (+1.1%)
- Blackrock Inc.: 8.5% (-16.7%)
- State Street Corpora: 4.8% (-3.3%)
- Dimensional Fund Adv: 4.8% (+1.5%)

### Key Risks

1. Insider selling cluster: $4.6M in recent transactions.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.47 indicates undervaluation relative to growth. Forward P/E 10.8x attractive for 26% earnings growth. Quality metrics strong (margin 17%). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.0B |
| Beta | 1.64 |
| 52W Range | $11.60 - $27.30 |
| Short Interest | 5.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.47 |
| Forward P/E | 10.8 |
| Current P/E | 13.6 |
| YoY Growth | 25.9% |
| EPS Direction | RISING |

### Technicals

MRS_10 stable at 5.3% (minimal 5-day change). Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 89th percentile. MRS_5 at 1.9% confirms short-term momentum alignment. Outperforming sector by 3.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 72, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.27% (CS: 89) | Strong |
| RSI_14 | 72.0 | Overbought |
| MACD Histogram | 0.30 | Bullish |
| vs SMA20 | 1.103x | Above |
| vs SMA50 | 1.131x | Above |
| vs SMA200 | 1.422x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $27.00
- **Stop Loss:** $25.38 (6.0% risk)
- **Target:** $29.43 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 851
- **Position Value:** $22,977.00
- **Portfolio %:** 22.98%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-27 (Est: $0.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.44 | $0.61 | +37.7% |
| 2025Q2 | $0.40 | $0.36 | -10.7% |
| 2025Q1 | $0.39 | $0.44 | +13.9% |
| 2024Q4 | $0.47 | $0.52 | +9.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*